- The role of angiotensin II type 1 receptor blockers in the prevention of cardiovascular disease. Editorial2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The role of angiotensin II type 1 receptor blockers (sartans) in the prevention of cardiovascular disease2005 | Faculty of Medicine in Pilsen
- Angiotensin receptor blockers in the treatment of arterial hypertension?2005 | First Faculty of Medicine
- Angiotensin Receptor Blocker Reduces Proteinuria Independently of Blood Pressure in Children Already Treated with Angiotensin-Converting Enzyme Inhibitors2009 | Second Faculty of Medicine
- AT(1) receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats2021 | First Faculty of Medicine, Second Faculty of Medicine
- Metabolic effect of imidasoline receptor blockers2006 | First Faculty of Medicine
- Alpha 1 receptor blockers and apoptosis2001 | First Faculty of Medicine
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cocotemporary cardiovascular pharmacotherapy2003 | First Faculty of Medicine
- The role of angiotensin II type 1 receptor blockers in the prevention of cardiovascular disease. Editorial2005 | Faculty of Medicine in Pilsen
- Sparsentan. Dual angiotensin II AT1 receptor blocker and endothelin ETA receptor antagonist, Treatment of focal segmental glomerulosclerosis, Treatment of IgA nephropathy2020 | First Faculty of Medicine
- Angiotensin II receptor blockers in the treatment of chronic heart failurePublication without faculty affiliation
- The role of angiotensin II-receptor blockers, type A1 in the therapy of arterial hypertension2003 | First Faculty of Medicine
- The effect of MK-801, NMDA receptor blocker, on the hippocampal LTP in Lurcher mutant mice2005 | Faculty of Medicine in Pilsen
- Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats2021 | Second Faculty of Medicine
- Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis2022 | First Faculty of Medicine
- Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice2018 | Third Faculty of Medicine, Central Library of Charles University
- Should renin-angiotensin system inhibitors be discontinued in patients with covid-19 infection?2022 | First Faculty of Medicine
- Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet2015 | Third Faculty of Medicine
- Prasugrel2012 | Third Faculty of Medicine
- Latest developments in the management of resistant hypertension2018 | First Faculty of Medicine
- Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial2008 | First Faculty of Medicine
- Treatment of resistant hypertension2013 | First Faculty of Medicine
- Evaluation of recent fixed-dose combination therapies in the management of hypertension2009 | Publication without faculty affiliation
- Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic Shock2014 | Third Faculty of Medicine
- Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT(1) receptor blockade2007 | Second Faculty of Medicine
- Letter: telmisartan-associated enteropathy - is there any class effect?2014 | Faculty of Medicine in Hradec Králové
- Sartan associated enteropathy - case report and review of the literature2016 | Faculty of Medicine in Hradec Králové
- Effects of combined endothelin a receptor and Renin-Angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized ren-2 hypertensive rats2012 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats2019 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Are proton pump inhibitors an effective and safe drug not only in the prophylaxis of gastrointestinal bleeding in antithrombotic treatment?2020 | Third Faculty of Medicine